Skip to main content
letter
. 2022 Dec 13;32:74–76. doi: 10.1016/j.jdcr.2022.12.001

Fig 1.

Fig 1

A, Ulcerated plaque with surrounding erythema at the vaccine site on the left upper arm at initial presentation. B, Subtle pink patch on right upper arm 5 months following initial presentation. C, Well-healed scar on left upper arm with no palpable masses or lymphadenopathy 5 months following initial presentation.